2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Geher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A
Published in Annals of the Rheumatic Diseases
Methodology
International treat-to-target recommendations developed from systematic literature reviews and expert consensus for axial spondyloarthritis.
Key Findings
NSAIDs remain first-line pharmacological therapy alongside regular exercise and physiotherapy, with biologics for inadequate responders; no dietary supplement is recommended as disease-modifying.
Conclusions
Supplements have no established disease-modifying role in ankylosing spondylitis and should be adjunctive only.
Limitations
Consensus recommendations rather than primary trial data.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.